GfK launches snapshot doc surveys

Share this article:

GfK launched a new product—Flashpoints—allowing marketers to survey 100 physicians in one week. 


The offering will provide a snapshot of physician behaviors or perceptions as they react to a market event or drug launch, for example. The customized survey allows for five close-ended questions, with the option of using open-ended questions for an additional charge, according to a GfK statement. "In circumstances where clients only require a topline market pulse on a given issue-of-the-moment—or when a decision needs to be made imminently—FlashPoints serves as an efficient way to gather reliable, representative and rapid feedback, said Maureen McLaughlin, chief marketing officer at GfK Healthcare, in the statement.


GfK is billing the service as the only one of its kind available. A spokesperson for IMS Health said IMS doesn't offer a comparable one-week survey, but can provide survey results for over 3,000 physicians on a quarterly basis for clients.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

FDA social media guides draw flak

FDA social media guides draw flak

Two FDA guidance documents on how health product manufacturers may participate in social media have drawn criticism from industry and consumer groups.